Richard J. Ablin

Corporate Officer/Principal at Tetragenex Pharmaceuticals, Inc.

Consumer Services

Health Technology

Richard J. Ablin active positions

Companies	Position	Start	End
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Corporate Officer/Principal	04/02/2010	-

Companies	Position	Start	End
The State University of New York	Director/Board Member	31/12/1988	31/12/1988
The State University of New York	Corporate Officer/Principal	31/12/1988	31/12/1988

State University of New York at Buffalo

Doctorate Degree

International

United States

Operational

Corporate Officer/Principal	2
Director/Board Member	1
Doctorate Degree	1

Sectoral

Consumer Services	3
Health Technology	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	1
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Health Technology

Private companies

Health Technology